Mehdi Gholam‐Rezaee

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

Philippe Conus, Larry J. Seidman, Margot Fournier et al. · Schizophrenia Bulletin · 2017 · 161 citations · Full text

Neuropsychology, Psychotropic Medication, Valid Biomarkers +19

Prospective associations of depression subtypes with cardio-metabolic risk factors in the general population

Aurélie M. Lasserre, Marie‐Pierre F. Strippoli, Jennifer Glaus et al. · Molecular Psychiatry · 2016 · 110 citations · Full text

Obesity, Metabolic Syndrome, Psychiatry +10

Interobserver agreement and validity of bedside ‘positive signs’ for functional weakness, sensory and gait disorders in conversion disorder: a pilot study

Corinna Daum, Fulvia Gheorghita, Marianna Spatola et al. · Journal of Neurology Neurosurgery & Psychiatry · 2014 · 101 citations

Mental disorders in offspring of parents with bipolar and major depressive disorders

Caroline L. Vandeleur, Stéphane Rothen, Mehdi Gholam‐Rezaee et al. · Bipolar Disorders · 2012 · 96 citations · Full text

Importance of Early Weight Changes to Predict Long-Term Weight Gain During Psychotropic Drug Treatment

Frederik Vandenberghe, Mehdi Gholam‐Rezaee, Núria Saigí-Morgui et al. · The Journal of Clinical Psychiatry · 2015 · 94 citations · Full text